Executive Committee: Belluscura plc

Manager
Positions heldSince
Robert Rauker

Robert Rauker

Chief Executive Officer 17/08/2016
Anthony Dyer

Anthony Dyer

57 year

Corporate Secretary 02/10/2023
Brian Brown

Brian Brown

Chief Operating Officer -

Composition of the Board of Directors: Belluscura plc

Director
CommitteesSince
Paul Tuson

Paul Tuson

59 year

Audit Committee Chair
Guy Peters

Guy Peters

64 year

Director/Board Member 11/09/2025

Former Officers and Directors: Belluscura plc

Insider
Positions held
SinceUntil
Ric Piper
Ric Piper
Director/Board Member 27/05/2021 21/09/2025
Independent Dir/Board Member 27/05/2021 21/09/2025
Simon Neicheril
Simon Neicheril
Director/Board Member 02/10/2023 01/05/2025
Director of Finance/CFO 02/10/2023 01/05/2025
Jonathan Satchell
Jonathan Satchell
Director/Board Member 08/02/2024 -
Independent Dir/Board Member 08/02/2024 -
Robert Fary
Robert Fary
Director/Board Member 13/06/2023 -
Sales & Marketing 15/01/2023 -
David Poutney
David Poutney
Director/Board Member 27/05/2021 -
Adam Reynolds
Adam Reynolds
Chairman 20/04/2021 -
Independent Dir/Board Member 20/04/2021 -
Patrick Strollo
Patrick Strollo
Director/Board Member 11/04/2021 -
Independent Dir/Board Member 11/04/2021 -
Robert Miller
Robert Miller
Chairman 31/03/2016 30/09/2017
Cary Parrott
Cary Parrott
Sales & Marketing 31/12/2015 -
Clifford Gross
Clifford Gross
Founder 09/12/2015 -
A. Inglis
A. Inglis
Director/Board Member - -
Michael N. van Hoy
Michael N. van Hoy
Director/Board Member - -
Chief Operating Officer - -
Bray Raymond
Bray Raymond
Compliance Officer - -

Age distribution of managers

Parity Men Women

Male7
Female0

Of which Executive Committee

Male3
Female0

Of which Directors

Male2
Female0
Logo Belluscura plc
Belluscura PLC is a United Kingdom-based medical device developer company. The Company is focused on developing lightweight and portable oxygen enrichment technology. The Company's product X-PLOR, is a modular portable oxygen concentrator. The X-PLOR is lightweight, specifically designed to replace metal oxygen tanks and heavier portable oxygen concentrator devices. The X-PLOR can deliver up to 95% pure oxygen to patients 24 hours a day, seven days a week. The Company is focused on developing medical devices who suffer from chronic lung diseases, such as the Chronic Obstructive Pulmonary Disease (COPD), respiratory distress caused by COVID-19, and many other respiratory disorders. It is also focused on developing, licensing and manufacturing portable oxygen concentrators for use in treating lung diseases with its oxygen platform technologies, to include recreational and industrial oxygen concentrators, wound care devices, drug delivery devices and more.
Employees
35

Departures of Key Persons

Adam Reynolds
-
Adam Reynolds

Chairman

20/04/2021 -

Robert Miller
-
Robert Miller

Chairman

31/03/2016 30/09/2017